Летрозол Тева

国家: 以色列

语言: 俄文

来源: Ministry of Health

有效成分:

LETROZOLE 2.5 MG

可用日期:

TEVA PHARMACEUTICAL INDUST.LTD

ATC代码:

L02BG04

药物剂型:

TABLETS

给药途径:

PER OS

厂商:

TEVA PHARMACEUTICAL INDUSTRIES LTD

治疗组:

LETROZOLE

疗效迹象:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

授权日期:

2010-01-01